G. Sanz and V. Fuster, “Fixed-Dose Combination Therapy and Secondary Cardiovascular Prevention: Rationale, Selection of Drugs and Target Population,” Nature Clinical Practice Cardiovascular Medicine, Vol. 6, No. 2, 2009, pp. 101-110.
 S. Yusuf, P. Pais, R. Afzal, et al., “Effects of a Polypill (Polycap) on Risk Factors in Middle-Aged Individuals without Cardiovascular Disease (TIPS): A Phase II, Double-Blind, Randomised Trial,” Lancet, Vol. 373, No. 9672, 2009, pp. 341-351.
 V. Kumar, R. P. Shah and S. Singh, “LC and LC-MS Methods for the Investigation of Polypills for the Treatment of Cardiovascular Diseases: Part.1Separation of Active Compo,” Journal of Pharmaceutical and Biomedical Analysis, Vol. 47, 2008, pp. 508-515.
 V. Kumar, S. Malik and S. Singh, “Polypill for the treatment of cardiovascular diseases: Part 2. LC-MS/TOF characterization of interaction/degradation products of atenolol/lisinopril,” Journal of Pharmaceutical and Biomedical Analysis, Vol. 48, No. 3, 2008, pp. 619-628.
 R. G. Bakker-Arkema, M. H. Davidson, R. J. Goldstein, “Efficacy and Safety of a New HMG-CoA Reductase Inhibitor, Atorvastatin, in Patients with Hypertriglyceri- demia,” Journal of the American Medical Association, Vol. 275, No. 2, 1996, pp. 128-133.
 B. M. Psaty, T. D. Koepsell, J. P. LoGerfo, et al., “B-Blockers and Primary Prevention of Coronary Heart Disease in Patients with High Blood Pressure,” Journal of the American Medical Association, Vol. 261, No. 14, 1989, pp. 2087-2094.
 E. R. Montgomery, S. Taylor, J. Segretario, et al., “Development and Validation of a Reversed-Phase Liquid Chromatographic Method for Analysis of Aspirin and Warfarin in a Combination Tablet Formulation,” Journal of Pharmaceutical and Biomedical Analysis, Vol. 15, No. 1, 1996, pp. 73-82.
 D. G. Sankar, M. S. M. Raju, K. Sumanth and P. V. M. Latha, “Asian HPLC Method for Estimation of Atorvastatin in Pure and Pharmaceutical Dosage Form,” Journal of Chemistry, Vol. 17, 2005, pp. 2571-2574.
 S. Erturk, A. E. Sevinc, L. Ersoy and S. Ficicioglu, “HPLC Method for the Determination of Atorvastatin and its Impurities in Bulk Drug and Tablets,” Journal of Pharmaceutical and Biomedical Analysis, Vol. 33, 2003, pp. 1017-1023.
 B. Stanisz and L. Kania, “Validation of HPLC Method for Determination of Atorvastatin in Tablets and for Monitoring in Solid Phase,” Acta Poloniae Pharmaceutica, Vol. 63, No. 6, 2006, pp. 471-476.
 G. Bahrami, B. Mohammadi, S. Mirzaeei and A. Kiani, “Determination of Atorvastatin in Human Serum by Reverse Phase High Performance Liquid Chromatography with UV Detection,” Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, Vol. 826, 2005, pp. 41-45.
 M. Jemal, Z. Ouyang, B. C. Chen and D. Teitz, “Quantitation of Atorvastatin and its Bio-Transformation Products in Human Serum by HPLC with Electro Spray Tandem Mass Spectrometry,” Rapid Communications in Mass Spectrometry, Vol. 13, 1999, pp. 1003-1015.
 M. Hermann, H. Christensen and J. L. Reubsaet, “Determination of Atorvastatin and Metabolites in Human Plasma with Solid Phase Extraction Followed by LC- Tandem MS,” Analytical and Bioanalytical Chemistry, Vol. 382, No. 5, 2005, pp. 1242-1249.
 S. R. Dhaneshwar, S. Yadav, A. Mhaske and S. Kadam, “HPTLC Method for Determination of Content Uni- formity of Atorvastatin Calcium Tablets,” Indian Journal of Pharmaceutical Sciences, Vol. 67, 2005, pp. 182-186.
 C. V. N. Prasad, C. Parihar, K. Sunil and P. Parimoo, “Simultaneous Determination of Amiloride, Hydrochloro- thiazide and Atenolol in Combined Formulation by Derivative Spectroscopy,” Journal of Pharmaceutical and Biomedical Analysis, Vol. 17, 1998, pp. 877-884.
 A. P. Agrekar and S. G. Powar, “Reverse Phase High Performance Liquid Chromatographic Determination of Ramipril and Amlodipine in Tablets,” Journal of Pharmaceutical and Biomedical Analysis, Vol. 21, 2000, pp. 1137-1142.
 M. B. Shankar, F. A. Metha, K. K. Bhatt, R. S. Metha and M. Geetha, “Simultaneous Spectrophotometric Determination of Losartan Potassium and Hydrochlorothiazide in Tablets,” Indian Journal of Pharmaceutical Sciences, Vol. 65, No. 2, 2003, pp. 167-170.
 C. F. Pedroso, J. G. de Oliveira, F. R. Campos, et al., “A Validated RP-LC Method for Simultaneous Determination of Losartan Potassium and Amlodipine Besilate in Pharmaceutical Preparations,” Chromatography, Vol. 69, Supplement 2, pp. 201-206.
 D. D. Rao, N. V. Satyanarayana, S. S. Sait, Y. R. Reddy and K. Mukkanti, “Simultaneous Determination of Losartan Potassium, Atenolol and Hydrochlorothiazide in Pharmaceutical Preparations by Stability-Indicating UPLC,” Chromatography, Vol. 70, No. 4, 2009, pp. 647-651.